IDEAYA Biosciences 8-K Filing Report: Key Updates & Insights
Based on the provided section of the financial report, here are the key details extracted:
- Filing Information:
- Filing Type: 8-K
- Filing Date: February 13, 2025
- Company Information:
- Company Name: IDEAYA Biosciences, Inc.
- CIK (Central Index Key): 0001676725
- SEC File Number: 001-38915
- EIN (Employer Identification Number): 47-4268251
- Address: 5000 Shoreline Court, Suite 300, South San Francisco, CA 94080
- Contact Number: (650) 443-6209
- Stock Information:
- Common Stock Par Value: $0.0001 per share
- Ticker Symbol: IDYA
- Exchange: NASDAQ
- Period Covered:
- Report Period Start Date: February 13, 2025
- Report Period End Date: February 13, 2025
Key Insights:
- The report is an 8-K filing, which typically indicates that the company is disclosing significant events that shareholders should be aware of.
- The filing date coincides with the report period, suggesting that the company may be reporting on an event that occurred on the same date.
- IDEAYA Biosciences, Inc. is listed on NASDAQ under the ticker IDYA, which provides a public trading context for its common stock.
- The information indicates a formal acknowledgment of corporate activities or changes that may impact investors or the market perception of the company.
This summary captures the essential elements necessary for understanding the context of the filing and its importance for stakeholders.